Topical Therapy for Androgenetic Alopecia Clinical Trial
A Clinical trial by Pelage Pharmaceuticals announces positive results for a topical therapy for androgenetic alopecia. It is designed to reactivate dormant hair follicle stem cells
The study below was published in the New England Journal of Medicine, entitiled "Two Phase 3 Trials of Baricitinib for Alopecia Areata".